MYT1L and malignant glioma: Previously, we and others have reported that the combined transcription factors (BRN2/ASCL1/ MYT1L or NGN2/SOX11) could reprogram human malignant glioma cells into terminally differentiated neuron-like cells and successfully impede brain tumor development [30,31].